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The main function of red blood cells (RBC), which is
mediated by Hb, is the transport of oxygen and carbon
dioxide in the body. In addition, RBC are strongly
involved in regulation of vascular tone especially under
hypoxic conditions. Hypoxic vasodilation is a fundamen-
tal physiological process which directly correlates with
the oxygen saturation of Hb in RBC. Since discovery in
1980s that NO is a biological signalling molecule,
numerous studies linked NO/Hb to the mechanisms
underlying hypoxic vasodilation. According to calcula-
tions, mathematical modelling, and experimental data
most of NO in blood is scavenged by Hb by the reaction
of deoxyHb with NO which results in formation of
metHb and nitrate. It has been also proposed that NO
can bind by nitrosylation reaction of conserved cysteine
on Hb b-chain (b93Cystein) to form SNO-Hb. Although
different reactions between NO and Hb are clear and
well established, the mechanisms of NO release from
Hb and how, in physiological conditions of high excess
of free Hb, NO can escape from scavenging by Hb are
not so well established. Importantly, till now, there was
never shown directly that RBC released biologically
active NO can activate soluble guanylyl cyclae (sGC) in
neighboring cells (platelets or vascular smooth muscle
cells).
Most experiments that prove NO release from RBC are
done in blood vessel relaxation or in isolated washed RBC.
However, both these experimental approaches are not suf-
ficient to clearly answer the question whether RBC can
produce biologically active NO because vasorelaxation is a
complex reaction which is not mediated only by NO and
in isolated RBC experiments it was never shown that RBC
produced NO or other NO related radicals could activate
sGC. To answer this question we used two different
approaches which allow to directly measure NO-mediated
activation of sGC in intact cells (platelets) and in purified
enzyme. Endogenous NO is a well-known and potent inhi-
bitor of platelet activation and platelet inhibitory effects of
NO are mediated solely by sGC activation. Intact platelet
sGC is highly sensitive to endogenous NO and even nano-
molar NO concentrations are sufficient for cGMP genera-
tion. In platelets, the main mediator of cGMP is PKG
which phosphorylates multiple substrates responsible for
platelet inhibition. For evaluation of platelet sGC activity
we used our well-established model based on NO/sGC/
cGMP/PKG dependent vasodilator-stimulated phospho-
protein (VASP) phosphorylation in human platelets and
purified sGC which is also very sensitive to low NO con-
centrations. In our experiments RBC were mixed with pla-
telet suspension or with purified enzyme and sGC
activation was assessed by VASP phosphorylation and
cGMP formation. All our experiments clearly show that
RBC, in any conditions, cannot be sources of NO, they act
only as a strong NO scavengers and all our data, albeit
indirectly, indicate that hypoxia/RBC induced vasodilation
is not mediated by NO derived from RBC.
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